To link your Twitter account with your DLD profile, we need you to enter your DLD Email and Password. You only do this once.
To link your Facebook account with your DLD profile, we need you to enter your DLD Email and Password. You only do this once.
Prof. Dr. Ugur Sahin, M.D. is a trained physician whose key interest is translating science into innovation enabling individualized high-precision treatment of cancer patients. As inventor he has made essential contributions to more than 70 independent patents in various life science and biotechnology fields. As entrepreneurial researcher he has founded corporations, in which his discoveries and disruptive technology innovations are developed to cancer diagnostics and therapies. Prof. Dr. Sahin has authored about 100 original research articles and has received various prestigious national and international awards for his scientific achievements. He is co-founder of the biotech companies Ganymed Pharmaceuticals and [BioNTech](http://biontech.de/). holding, the latter he leads as CEO. He is co-founder of the German Cutting Edge Cluster Initiative for Individualized Immune Intervention and co-founder and chair of the not-for-profit translational research institute [TRON](http://tron-mainz.de/).